Stem cells may mend liver damage

Researchers have found a way to reprogram cells from mouse tails to behave like mature liver cells, which appear to be able to repair damaged livers.

By | May 14, 2011

Fatty liver diseaseNEPHRON / WIKIPEDIA

Researchers have found a way to reprogram cells from mouse tails to behave like mature liver cells, which appear to be able to repair damaged livers, according to a study published this week in Nature. The paper is proof of the concept that reprogrammed cells can skip the pluripotency stage and still hold therapeutic value. Cell biologist Lijian Hui of the Shanghai Institute for Biological Sciences in China and his colleagues expressed three proteins, and suppressed one, to reprogram fibroblasts from mouse tails into liver-like cells, which they then transplanted into mutant mice that were unable to detoxify certain metabolic intermediates. Five of the 12 animals that received the engineered cells survived, while all control animals died.

"It's really exciting," Paul Gadue, a stem-cell biologist at the Children's Hospital of Philadelphia in Pennsylvania who was not involved in the study, told Nature. "If this work could be translated to humans, it could be very powerful."

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech